Medtronic (NYSE:MDT) this week said it took out a stake with an exclusive option to buy in Arsenal Medical subsidiary Arsenal AAA. Arsenal AAA is developing a hemostatic foam and delivery system designed to reduce the chance of endoleaks after the placement of a stent graft to treat an abdominal aortic aneurysm. Arsenal president & CEO Maria Palasis told MassDevice.com that the product is designed […]